Disappointing result today
However am I missing something here....
If the results have shown Xanamem effectively decreases cortisol production
and the company are confident (if its not been proven) that there is a link between cortisol and cognition
then surely its just a case of working out the correct dosage/time frame to show that Xanamem impacts cognition???
Or is that too simplistic?
My only concern or question for Bill is if there was a slim chance of a 10mg dose over 12 weeks showing an impact why was this not made clear in all the presentations?
Someone mentioned that the trial was initially supposed to be for 30mg but FDA pushed back....frustrating!
- Forums
- ASX - By Stock
- ACW
- Ann: Phase II Alzheimer's Disease Trial - results
Ann: Phase II Alzheimer's Disease Trial - results, page-57
-
- There are more pages in this discussion • 399 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ACW (ASX) to my watchlist
|
|||||
Last
2.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $65.08M |
Open | High | Low | Value | Volume |
2.4¢ | 2.5¢ | 2.1¢ | $526.7K | 22.84M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 431842 | 2.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.4¢ | 499979 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 344886 | 0.023 |
8 | 2367558 | 0.022 |
8 | 1493218 | 0.021 |
23 | 3169396 | 0.020 |
7 | 2536684 | 0.019 |
Price($) | Vol. | No. |
---|---|---|
0.024 | 499979 | 1 |
0.025 | 2793761 | 6 |
0.026 | 3070150 | 9 |
0.027 | 1612009 | 5 |
0.028 | 675157 | 2 |
Last trade - 16.10pm 23/08/2024 (20 minute delay) ? |
ACW (ASX) Chart |
The Watchlist
SER
STRATEGIC ENERGY RESOURCES LIMITED
David DeTata, Managing Director
David DeTata
Managing Director
SPONSORED BY The Market Online